Big Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart Failure
BEAT-HF
Big Data and Real-world Evidence to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart Failure: the BEAT-HF Study
1 other identifier
observational
7,860,560
1 country
1
Brief Summary
The goal of this observational study is to define the incidence of heart failure (HF) after acute coronary syndrome (ACS). The main question it aims to answer is: • To define HF incidence in the medium and long-term in the context of public healthcare coverage ensuring universal access to early coronary revascularization after ACS and extended neurohormonal treatment. Analyses will cover the entire population of Catalonia (North-Eastern region of Spain, N = 7.860.563 in 2020). Researchers will compare HF incidence rate according to relevant subgroup characteristics including event type, age groups or sex, inter alia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
February 4, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedFebruary 16, 2024
February 1, 2024
10 years
February 4, 2024
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Baseline characteristics
The first co-primary outcome is to define the baseline characteristics of the ACS population, overall and according to clinical interest groups including event type (STEMI, NSTEMI, UA) and other relevant subgroups of patients.
Between January 1st, 2012 and 31st, December 2021 (study period).
Incidence of heart failure after acute coronary syndrome
The second co-primary outcome of the study is the incidence rate of HF after ACS of all patients discharged alive after an ACS in Catalonia
Between January 1st, 2012 and 31st, December 2021 (study period).
Secondary Outcomes (2)
Clinical endpoints
Between January 1st, 2012 and 31st, December 2021 (study period).
Healthcare resource use endpoints
Between January 1st, 2012 and 31st, December 2021 (study period).
Eligibility Criteria
Analyses will cover the entire population of Catalonia (Spain, N = 7.860.563 as of December 31st, 2020), a region in which the Catalan Health Service granted universal health coverage.
You may qualify if:
- Admission with the primary diagnosis of acute coronary syndrome ( Non-ST-Elevation Myocardial Infarction -NSTEMI-, ST-Elevation Myocardial Infarction -STEMI-, Unestable Angina -UA-)
You may not qualify if:
- Death before discharge from index event.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Innovation, Research and Universities of the South-Metropolitan Healthcare Area
Study Record Dates
First Submitted
February 4, 2024
First Posted
February 13, 2024
Study Start
January 1, 2012
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
February 16, 2024
Record last verified: 2024-02